Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nestorone QT/QTc study in healthy females
NCT02236026Phase 1Completed
- Sponsor
- Population Council
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of segesterone in contraception (3 arms), sponsored by Population Council. Primary endpoint: Corrected QT interval using Fridericia's formula. Started Sep 2014; status: completed.
02
Drugs
segesterone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02236026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02236026.